1. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Issue 1 (1st January 2023) Authors: Rosenberg, Jonathan E.; Park, Se Hoon; Kozlov, Vadim; Dao, Tu V.; Castellano, Daniel; Li, Jian-Ri; Mukherjee, Som D.; Howells, Kathryn; Dry, Hannah; Lanasa, Mark C.; Stewart, Ross; Bajorin, Dean F. Journal: Journal of clinical oncology Issue: Volume 41:Issue 1(2023) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase. Issue 18 (15th September 2020) Authors: Kawatkar, Sameer P.; Barlaam, Bernard; Kemmitt, Paul; Simpson, Iain; Watson, David; Wang, Peng; Lamont, Scott; Su, Qibin; Boiko, Scott; Ikeda, Timothy; Patel, Joe; Pike, Andy; Pollard, Hannah; Read, Jon; Sarkar, Ujjal; Wang, Haiyun; Wen, Quanshan; Yan, Zhiyuan; Dowling, James E.; Dry, Hannah Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 18(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors. Issue 22 (15th November 2020) Authors: Barlaam, Bernard; Boiko, Scott; Boyd, Scott; Dry, Hannah; Gingipalli, Lakshmaiah; Ikeda, Timothy; Johnson, Tony; Kawatkar, Sameer; Lorthioir, Olivier; Pike, Andy; Pollard, Hannah; Read, Jon; Su, Qibin; Wang, Haiyun; Wang, Huimin; Wang, Lianghe; Wang, Peng; Edmondson, Scott D. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial. (4th December 2022) Authors: Monk, Bradley; Toita, Takafumi; Wu, Xiaohua; Carlos Limón, Juan; Zhou, Qi; Tarnawski, Rafal; Mandai, Masaki; Shapira-Frommer, Ronnie; Mahantshetty, Umesh; Del Pilar Estevez-Diz, Maria; Ramirez Godinez, Francisco; Varga, Szilvia; Leiva Gálvez, Manuel Humberto; Lee, Jung-Yun; Kreynina, Yulia; Howel... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimization of a series of potent, selective and orally bioavailable SYK inhibitors. Issue 19 (1st October 2020) Authors: Grimster, Neil P.; Gingipalli, Lakshmaiah; Barlaam, Bernard; Su, Qibin; Zheng, XiaoLan; Watson, David; Wang, Haixia; Simpson, Iain; Pike, Andy; Balazs, Amber; Boiko, Scott; Ikeda, Timothy P.; Impastato, Anna C.; Jones, Natalie H.; Kawatkar, Sameer; Kemmitt, Paul; Lamont, Scott; Patel, Joe; Read, ... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 19(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗